Annual D&A
$419.00 K
-$94.00 K-18.32%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual depreciation & amortization is $419.00 thousand, with the most recent change of -$94.00 thousand (-18.32%) on December 31, 2023.
- During the last 3 years, XFOR annual D&A has risen by +$68.00 thousand (+19.37%).
- XFOR annual D&A is now -18.32% below its all-time high of $513.00 thousand, reached on December 31, 2022.
Performance
XFOR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$267.00 K
+$73.00 K+37.63%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly depreciation & amortization is $267.00 thousand, with the most recent change of +$73.00 thousand (+37.63%) on September 30, 2024.
- Over the past year, XFOR quarterly D&A has increased by +$73.00 thousand (+37.63%).
- XFOR quarterly D&A is now at all-time high.
Performance
XFOR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$585.00 K
+$163.00 K+38.63%
September 30, 2024
Summary
- As of February 12, 2025, XFOR TTM depreciation & amortization is $585.00 thousand, with the most recent change of +$163.00 thousand (+38.63%) on September 30, 2024.
- Over the past year, XFOR TTM D&A has increased by +$163.00 thousand (+38.63%).
- XFOR TTM D&A is now at all-time high.
Performance
XFOR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XFOR Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -18.3% | +37.6% | +38.6% |
3 y3 years | +19.4% | +37.6% | +38.6% |
5 y5 years | +306.8% | +888.9% | +468.0% |
XFOR Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -18.3% | at low | at high | +330.6% | at high | +65.3% |
5 y | 5-year | -18.3% | +306.8% | at high | +734.4% | at high | +468.0% |
alltime | all time | -18.3% | +306.8% | at high | +1583.3% | at high | +1118.8% |
X4 Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $267.00 K(+37.6%) | $585.00 K(+38.6%) |
Jun 2024 | - | $194.00 K(+212.9%) | $422.00 K(+19.2%) |
Mar 2024 | - | $62.00 K(0.0%) | $354.00 K(-15.5%) |
Dec 2023 | $419.00 K(-18.3%) | $62.00 K(-40.4%) | $419.00 K(-12.9%) |
Sep 2023 | - | $104.00 K(-17.5%) | $481.00 K(-4.0%) |
Jun 2023 | - | $126.00 K(-0.8%) | $501.00 K(-1.2%) |
Mar 2023 | - | $127.00 K(+2.4%) | $507.00 K(-1.2%) |
Dec 2022 | $513.00 K(+2.8%) | $124.00 K(0.0%) | $513.00 K(-1.5%) |
Sep 2022 | - | $124.00 K(-6.1%) | $521.00 K(-1.5%) |
Jun 2022 | - | $132.00 K(-0.8%) | $529.00 K(+0.6%) |
Mar 2022 | - | $133.00 K(+0.8%) | $526.00 K(+5.4%) |
Dec 2021 | $499.00 K(+42.2%) | $132.00 K(0.0%) | $499.00 K(+6.2%) |
Sep 2021 | - | $132.00 K(+2.3%) | $470.00 K(-2.9%) |
Jun 2021 | - | $129.00 K(+21.7%) | $484.00 K(+15.0%) |
Mar 2021 | - | $106.00 K(+2.9%) | $421.00 K(+19.9%) |
Dec 2020 | $351.00 K | $103.00 K(-29.5%) | $351.00 K(+25.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | $146.00 K(+121.2%) | $280.00 K(+73.9%) |
Jun 2020 | - | $66.00 K(+83.3%) | $161.00 K(+35.3%) |
Mar 2020 | - | $36.00 K(+12.5%) | $119.00 K(+15.5%) |
Dec 2019 | $103.00 K(0.0%) | $32.00 K(+18.5%) | $103.00 K(+94.3%) |
Sep 2019 | - | $27.00 K(+12.5%) | $53.00 K(-14.5%) |
Jun 2019 | - | $24.00 K(+20.0%) | $62.00 K(-19.5%) |
Mar 2019 | - | $20.00 K(-211.1%) | $77.00 K(-25.2%) |
Dec 2018 | $103.00 K(-47.2%) | -$18.00 K(-150.0%) | $103.00 K(-38.7%) |
Sep 2018 | - | $36.00 K(-7.7%) | $168.00 K(-8.7%) |
Jun 2018 | - | $39.00 K(-15.2%) | $184.00 K(-4.7%) |
Mar 2018 | - | $46.00 K(-2.1%) | $193.00 K(-1.0%) |
Dec 2017 | $195.00 K(-31.6%) | $47.00 K(-9.6%) | $195.00 K(+31.8%) |
Sep 2017 | - | $52.00 K(+8.3%) | $148.00 K(+54.2%) |
Jun 2017 | - | $48.00 K(0.0%) | $96.00 K(+100.0%) |
Mar 2017 | - | $48.00 K | $48.00 K |
Dec 2016 | $285.00 K(-26.7%) | - | - |
Dec 2015 | $389.00 K | - | - |
FAQ
- What is X4 Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual D&A year-on-year change?
- What is X4 Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly D&A year-on-year change?
- What is X4 Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM D&A year-on-year change?
What is X4 Pharmaceuticals annual depreciation & amortization?
The current annual D&A of XFOR is $419.00 K
What is the all time high annual D&A for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual depreciation & amortization is $513.00 K
What is X4 Pharmaceuticals annual D&A year-on-year change?
Over the past year, XFOR annual depreciation & amortization has changed by -$94.00 K (-18.32%)
What is X4 Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of XFOR is $267.00 K
What is the all time high quarterly D&A for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly depreciation & amortization is $267.00 K
What is X4 Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, XFOR quarterly depreciation & amortization has changed by +$73.00 K (+37.63%)
What is X4 Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of XFOR is $585.00 K
What is the all time high TTM D&A for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM depreciation & amortization is $585.00 K
What is X4 Pharmaceuticals TTM D&A year-on-year change?
Over the past year, XFOR TTM depreciation & amortization has changed by +$163.00 K (+38.63%)